IRegained Inc. is a MedTech company born out of 50 years of dedicated hard work and collective research in Physiotherapy, Neurophysiology, and Neuroplasticity for brain function recovery combined with advanced engineering and cutting-edge technology.
Our latest medical innovation The MyHandTM System helps those who suffer from hand function impairment due to brain injury caused by a stroke or an accident.
We acknowledge how much of a devastating blow a stroke becomes, both for the person affected and for other members of the family.
We can’t undo a stroke, however, we are building The MyHandTM System that can help patients worldwide recover from hand function disability and live independently once again.
The significant need for this device is simply evident from some staggering facts.
According to the data provided by WHO (World Health Organization) and the CDC (Centers for Disease Control and Prevention) in the USA, each year 795,000 people get a stroke in the USA and 15 million worldwide. That is 1 person every 2 seconds.
Over 70% of stroke survivors suffer from some degree of paralysis in their hands. They unfortunately are forced to live with this disability for life which averages at 10 years post-stroke. Thus, more than 100 million people worldwide are in dire need of an effective, affordable, and accessible hand function rehabilitation solution.
These facts certainly identify the dire unmet need and inspire us to work on a war footing to serve a hundred million people who undergo this dreadful experience and live with compromised quality of life due to hand function disability.
Globally the rehabilitation equipment and devices market is valued at USD 13.4 billion in 2019
and is expected to grow at a CAGR of 7.2%.
At IRegained, we realize that the invention of this device, is only the beginning, and we have ensured that our patent-pending and clinically effective MyHandTM System reaches the patient through the most effective channels.
To achieve this, we plan to use an effective B2B2C business strategy. Some of the concrete steps in this direction include:
Selling the system to rehab clinics that will use the device in their therapy practices and also promote it to their Clients.
Work with insurers, by educating them of the savings from the rapid recovery & potential return of the patients to work that will happen with the use of this device.
As compared to the highly expensive robotic and ineffective passive devices like squeeze balls, this system brings a revolution not only in terms of ease of use but also in terms of affordability and adaptability.
Promote patient education through hand function rehabilitation classes to stroke support groups and create a passive market pull. The head-turning benefits of this device compared to anything else available will motivate stroke patients to reach out to rehabilitation centers to access this device.
A serious requirement of social distancing due to Covid-19 is easily adhered while operating The MyHandTM System in the comfort zone of home due to an integrated telemedicine platform.
Remote telemedicine guidance not only provides the therapists an efficient mode of healthcare service delivery improving their bottom-line but also an avenue for the vulnerable stroke population to get access to rehabilitation services without exposing themselves to COVID-19.
BSc.PT., PG.Dip.PT., MSc, Ph.D. (c)
B.E., MBA (Purdue University, USA)
BSc.PT. (Christian Medical College & Hospital-India)